
Syd Labs, Inc.于 2010 年初创立于美国波士顿,采用重组技术生产有活性的蛋白质,包括重组抗体、重组抗原、重组酶、重组细胞因子以及其它重组蛋白,努力提高蛋白产量和活性、降低成本和价格、尽量避免使用动物作为生产工具。
悉得实验室(Syd Labs, 简称"悉得”)强烈呼吁珍爱生命、减少使用动物生产抗体!
悉得(Syd Labs)重点推荐
| Anti-mouse antibodies(in vivo) | 体内实验级重组抗小鼠靶点抗体 |
| Isotype control antibodies | 同型对照抗体 |
| Research gradebiosimilars | 科研级生物类似药 |
| Anti-human antibodies(in vivo) | 体内实验级重组抗人靶点抗体 |
体内实验级重组抗小鼠靶点抗体
| 货号 | 产品名称 | 规格 |
| PA007162.r2a | Anti-mousePD-1(cloneRMP1-14.1),rIgG2a | 1mg;5mg;25mg |
| PA007163.r2a | Anti-mousePD-1(clone29F.1A12.1),rIgG2a | 1mg;5mg;25mg |
| PA007164.r2b | Anti-mousePD-L1(clone10F.9G2.1),rIgG2b | 1mg;5mg;25mg |
| PA007162.m2aLA | Anti-mousePD-1(cloneRMP1-14.1),mIgG2aLALAPG | 1mg;5mg;25mg |
| PA007162.m2cLA | Anti-mousePD-1(cloneRMP1-14.1),mIgG2cLALAPG | 1mg;5mg;25mg |
| PA007163.m2aLA | Anti-mousePD-1(clone29F.1A12.1),mIgG2aLALAPG | 1mg;5mg;25mg |
| PA007163.m2cLA | Anti-mousePD-1(clone29F.1A12.1),mIgG2cLALAPG | 1mg;5mg;25mg |
| PA007164.m2aLA | Anti-mousePD-L1(clone10F.9G2.1),mIgG2aLALAPG | 1mg;5mg;25mg |
| PA007164.m2cLA | Anti-mousePD-L1(clone10F.9G2.1),mIgG2cLALAPG | 1mg;5mg;25mg |
| PA007199.r2b | Anti-mouseCD3(clone17A2),rIgG2b | 1mg;5mg;25mg |
| PA007198 | Anti-mouseCD3e(clone145-2C11),mIgG2a | 1mg;5mg;25mg |
| PA007201 | Anti-mouseCD3e(clone500A2),mIgG2a | 1mg;5mg;25mg |
| PA007200.r2b | Anti-mouseCD4(cloneGK1.5),rIgG2b | 1mg;5mg;25mg |
| PA007166.r2b | Anti-MouseCD8a(cloneYTS169.4),rIgG2b | 1mg;5mg;25mg |
| PA007167.r2b | Anti-MouseCD8a(clone2.43),rIgG2b | 1mg;5mg;25mg |
| PA007363.r2a | Anti-mouseCD19(clone1D3),rIgG2a | 1mg;5mg;25mg |
| PA007156.r1 | Anti-mouseCD25(clonePC61.5.3),rIgG1Lambda | 1mg;5mg;25mg |
| PA007274.r2a | Anti-mouseCD40(cloneFGK4.5),rIgG2a | 1mg;5mg;25mg |
| PA007276.r2a | Anti-mouseCD137(TNFRSF9/4-1BB)(clone3H3),rIgG2a | 1mg;5mg;25mg |
| PA007275.r1 | Anti-mouseCD137(TNFRSF9/4-1BB)(cloneLOB12.3),rIgG1 | 1mg;5mg;25mg |
| PA007168.r1 | Anti-mouseOX40(cloneOX86),rIgG1 | 1mg;5mg;25mg |
| PA007280.m2a | Anti-mouseTIGIT(clone1F4),mIgG2a | 1mg;5mg;25mg |
| PA007279.m2a | Anti-mouseTIGIT(clone10A7),mIgG2a | 1mg;5mg;25mg |
| PA007169.r2b | Anti-mouseGITR(cloneDTA-1),rIgG2aLambda | 1mg;5mg;25mg |
同型对照抗体
| 货号 | 产品名称 | 规格 |
| PA007125 | HumanIgG1Isotype Control Antibody | 1mg;5mg;25mg |
| PA007128 | HumanIgG4-S228PIsotypeControlAntibody | 1mg;5mg;25mg |
| PA007134 | HumanIgG1-LALAPGIsotypeControl Antibody | 1mg;5mg;25mg |
| PA007133 | HumanIgG1-N297AIsotypeControlAntibody | 1mg;5mg;25mg |
| PA007132 | HumanIgG1-D265AIsotypeControlAntibody | 1mg;5mg;25mg |
| PA007127 | HumanIgG2Isotype Control Antibody | 1mg;5mg;25mg |
| PA007187 | ChimericHumanIgG1IsotypeControl Antibody | 1mg;5mg;25mg |
| PA007165.h1 | VHH-hIgG1FcIsotype Control Antibody | 1mg;5mg;25mg |
| PA007126 | MouseIgG1Isotype Control Antibody | 1mg;5mg;25mg |
| PA007135 | MouseIgG1-D265AIsotypeControlAntibody | 1mg;5mg;25mg |
| PA007129 | MouseIgG2aIsotype Control Antibody | 1mg;5mg;25mg |
| PA007138 | MouseIgG2a-LALAPGIsotypeControl Antibody | 1mg;5mg;25mg |
| PA007130 | MouseIgG2bIsotype Control Antibody | 1mg;5mg;25mg |
| PA005171 | MouseIgG2cIsotype Control Antibody | 1mg;5mg;25mg |
| PA007141 | MouseIgG2c-LALAPGIsotype Control Antibody | 1mg;5mg;25mg |
| PA007161 | MouseIgG3Isotype Control Antibody | 1mg;5mg;25mg |
| PA007142 | RatIgG1Isotype Control Antibody | 1mg;5mg;25mg |
| PA007143 | RatIgG2aIsotype Control Antibody | 1mg;5mg;25mg |
| PA007144 | RatIgG2bIsotype Control Antibody | 1mg;5mg;25mg |
| PA007145 | RatIgG2cIsotype Control Antibody | 1mg;5mg;25mg |
| PA007153.m1 | Anti-HEL(D1.3)MouseIgG1IsotypeControlAntibody | 1mg;5mg;25mg |
| PA007154.m1 | Anti-HEL(HyHEL-10)MouseIgG1IsotypeControlAntibody | 1mg;5mg;25mg |
| PA007155.m1 | MOPC-21MouseIgG1IsotypeControlAntibody | 1mg;5mg;25mg |
| PA007158.m1 | Anti-DNPMouseIgG1Isotype Control Antibody | 1mg;5mg;25mg |
| PA007151.m1 | B1-8MouseIgG1IsotypeControlAntibody | 1mg;5mg;25mg |
| PA007165.m2a | VHH-mIgG2aFcIsotype Control Antibody | 1mg;5mg;25mg |
| BP4091 | HumanIgG1FcProtein | 1mg;5mg;25mg |
| BP4092 | HumanIgG2FcProtein | 1mg;5mg;25mg |
| BP4125 | HumanIgG3FcProtein | 1mg;5mg;25mg |
| BP4093 | HumanIgG4FcProtein | 1mg;5mg;25mg |
| BP4111 | MouseIgG1FcProtein | 1mg;5mg;25mg |
| BP4120 | MouseIgG2aFcProtein | 1mg;5mg;25mg |
| BP4121 | MouseIgG2bFcProtein | 1mg;5mg;25mg |
| BP4123 | MouseIgG2cFcProtein | 1mg;5mg;25mg |
| BP4124 | MouseIgG3FcProtein | 1mg;5mg;25mg |
| BP4126 | RatIgG2aFcProtein | 1mg;5mg;25mg |
| BP4127 | RatIgG2bFcProtein | 1mg;5mg;25mg |
| BP4122 | RabbitIgGFcProtein | 1mg;5mg;25mg |
| BP4119 | LlamaIgG2bFcProtein | 1mg;5mg;25mg |
科研级生物类似药
| 货号 | 产品名称 | 规格 |
| C007P | AbataceptBiosimilar | 1mg;5mg;20mg |
| C003P | AdalimumabBiosimilar,Human TNF alpha | 1mg;5mg;20mg |
| C013P | AfliberceptBiosimilar | 1mg;5mg;20mg |
| C040P | AlemtuzumabBiosimilar,Human CD52 | 1mg;5mg;20mg |
| C024P | AtezolizumabBiosimilar,HumanPD-L1 | 1mg;5mg;20mg |
| C008P | BelataceptBiosimilar | 1mg;5mg;20mg |
| C001P | BevacizumabBiosimilar,Human VEGF | 1mg;5mg;20mg |
| C041P | BriakinumabBiosimilar,HumanIL-12 /IL-23 | 1mg;5mg;20mg |
| C002P | CetuximabBiosimilar,HumanEGFR | 1mg;5mg;20mg |
| C042P | ClenoliximabBiosimilar,HumanCD4 | 1mg;5mg;20mg |
| C043P | DaclizumabBiosimilar,HumanCD25 | 1mg;5mg;20mg |
| C030P | DaratumumabBiosimilar,HumanCD38 | 1mg;5mg;20mg |
| C004P | DenosumabBiosimilar,HumanRANKL | 1mg;5mg;20mg |
| C044P | DrozitumabBiosimilar,Human TRAIL | 1mg;5mg;20mg |
| C022P | EculizumabBiosimilar,HumanC5 | 1mg;5mg;20mg |
| C045P | EfalizumabBiosimilar,HumanCD11a | 1mg;5mg;20mg |
| C046P | EpratuzumabBiosimilar,HumanCD22 | 1mg;5mg;20mg |
| C058P | IbalizumabBiosimilar,HumanCD4 | 1mg;5mg;20mg |
| C011P | InfliximabBiosimilar,Human TNFalpha | 1mg;5mg;20mg |
| C033P | MinretumomabBiosimilar,Human TAG-72 | 1mg;5mg;20mg |
| C055P | NatalizumabBiosimilar,HumanIntegrinalpha 4 | 1mg;5mg;20mg |
| C026P | NivolumabBiosimilar,HumanPD-1 | 1mg;5mg;20mg |
| C020P | OmalizumabBiosimilar,HumanIgE | 1mg;5mg;20mg |
| C021P | PalivizumabBiosimilar,RSV | 1mg;5mg;20mg |
| C012P | PanitumumabBiosimilar,HumanEGFR/ErbB-1/HER1 | 1mg;5mg;20mg |
| C027P | PembrolizumabBiosimilar,HumanPD-1 | 1mg;5mg;20mg |
| C006P | PertuzumabBiosimilar,HumanHER2 | 1mg;5mg;20mg |
| C052P | PolatuzumabBiosimilar,HumanCD79B | 1mg;5mg;20mg |
| C005P | RanibizumabBiosimilar,Human VEGFFragment(Fab) | 1mg;5mg;20mg |
| C062P | RelatlimabBiosimilar,HumanLAG-3 | 1mg;5mg;20mg |
| C010P | RituximabBiosimilar,HumanCD20 | 1mg;5mg;20mg |
| C071P | SacituzumabBiosimilar,Human Trop-2 | 1mg;5mg;20mg |
| C034P | SecukinumabBiosimilar,HumanIL17A | 1mg;5mg;20mg |
| C110P | TanezumabBiosimilar,HumanNGF | 1mg;5mg;20mg |
| C056P | TeplizumabBiosimilar,Human CD3e | 1mg;5mg;20mg |
| C032P | TocilizumabBiosimilar,HumanIL-6R | 1mg;5mg;20mg |
| C009P | TrastuzumabBiosimilar,HumanHER2 | 1mg;5mg;20mg |
| C037P | TremelimumabBiosimilar,HumanCTLA-4 | 1mg;5mg;20mg |
| C038P | UstekinumabBiosimilar,HumanIL-12 /IL-23 | 1mg;5mg;20mg |
| C070P | ZolbetuximabBiosimilar, HumanClaudin18.2 | 1mg;5mg;20mg |
体内实验级重组抗人靶点抗体
| 货号 | 产品名称 | 规格 |
| PA007157.m1 | Anti-HumanHER2/ErbB-2/c-neu(clonemuMab 4D5),mIgG1 | 1mg;5mg;25mg |
| PA007196 | Anti-humanCD3(cloneSP34-2),mIgG1 | 1mg;5mg;25mg |
| PA007197 | Anti-humanCD3e(cloneUCHT1),mIgG1 | 1mg;5mg;25mg |
| PA007202.m2a | Anti-humanCD3e(cloneOKT3),mIgG2a | 1mg;5mg;25mg |
| PA007277.m1 | Anti-humanCD16(clone3G8),mIgG1 | 1mg;5mg;25mg |
| PA007271.m2a | Anti-humanCD19(cloneFMC63),mIgG2a | 1mg;5mg;25mg |
| PA007270.m1 | Anti-humanCD19(cloneSJ25C1),mIgG1 | 1mg;5mg;25mg |
| PA007272.m2a | Anti-humanCD19(cloneB43),mIgG2a | 1mg;5mg;25mg |
| PA007273.m2a | Anti-humanSiglec-2/CD22(cloneNCIm971),mIgG2a | 1mg;5mg;25mg |
| PA007278.m1 | Anti-humanCD56(cloneN901),mIgG1 | 1mg;5mg;25mg |
标签抗体
| 货号 | 产品名称 | 规格 |
| PA000274.m1 | Anti-DYKDDDDK-Tag(cloneM2.1),mIgG1 | 50ug;100ug;200ug;1mg;5mg |
| PA000002.m1 | Anti-Myc-Tag(clone 9E10),mIgG1 | 50ug;100ug;200ug;1mg;5mg |
| PA007281.m2b | Anti-HA-Tag(clone12CA5),mIgG2b | 50ug;100ug;200ug;1mg;5mg |
| PA007282.m2b | Anti-His-Tag(clone 3D5),mIgG2b | 50ug;100ug;200ug;1mg;5mg |
D-荧光素钾盐
| 货号 | 产品名称 | 规格 |
| MB000102-R70170 | D-LuciferinPotassium Salt | 1g;10g |
悉得(Syd Labs)技术优势
1 、 采用抗体药物生产中常用的化学成分确定的培养基和 CHO 细胞,没有来自 小鼠腹水和细胞培养基里 FBS 的抗体污染, 没有杂交瘤批次之间的不稳定性;
2 、 可以进行自由工程改造,包括切换 isotype 、Fc 突变、提升亲和力和产量;
3 、 在同等内毒素标准下价格比国外同行低至 50% ,内毒素可低至 0.05 EU/mg (FDA 对临床产品的质量要求),属于当前科研抗体内毒素水平的天花板。